Clinical Trial

Annatto-derived GG for Statin-associated Myopathy

Study acronym: GG-statin
Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
To evaluate the effects of 3-months annatto-derived geranylgeraniol (GG) supplementation on statin-associated skeletal muscle health.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-04-01; most recent amendment 2025-09-05.
Status change: Not Yet Recruiting → Recruiting 2022-12-07
Trial Details
NCT Number NCT05312424
Lead Sponsor Texas Tech University Health Sciences Center
Conditions Myopathy; Primary
Enrollment 95 participants
Start Date 2022-07-15
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-12